StockData
Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc. (RANI) stock

RANINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3043% above fair value
$0.56+0.02 (+3.54%)

Close on Nov 17, 2026Market cap $77.98MP/E –Yield –

Rani Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

No price to book ratio figures for Rani Therapeutics

Rani Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Rani Therapeutics figures

See a number that looks wrong?